According to the Organization for Economic Cooperation and Development (OECD), Russia is the most educated country in the world, overtaking Canada, Japan, Israel and the United States. More than half of Russians have higher education. More than 270,000 people from 168 countries of the world come to study at Russian universities annually. Education in Russia [...]
N.B. Lazareva1, E.V. Shikh1, E.V. Rebrova1, A.Yu. Ryazanova2 1 First Moscow State Medical University. THEM. Sechenov (Sechenovsky University), Moscow, Russian Federation 2 Volgograd State Medical University, Volgograd, Russian Federation The rapid progress in the creation and use of a huge number of drugs (MP), on the one hand, makes it possible to increase the effectiveness [...]
DOI: 10.15690 / vsp.v18i3.2032 A.V. Matveev1, 2, A.E. Krasheninnikov1, E.A. Egorova2, E.I. Konyaeva2, K.N. Koryanova3 1 National Research Center for Pharmacovigilance, Moscow, Russian Federation 2 Medical Academy. S.I. Georgievsky as a part of the Crimean Federal University them. IN AND. Vernadsky, Simferopol, Republic of Crimea, Russian Federation 3 Pyatigorsk Medical and Pharmaceutical Institute - a [...]
A.V. Matveev1,2, A.E. Krasheninnikov1, E.A. Egorova2 1 - National Research Center for Pharmacovigilance, Moscow, Russian Federation; 2 - Crimean Federal University V.I. Vernadsky, Medical Academy. S. I. Georgievsky, Simferopol, Russian Federation Drug use is inherently associated with adverse drug reactions (ADRs). According to WHO-ART, the Adverse reaction terminology (ART) developed by the World Health Organization [...]
A.E. Krasheninnikov, Cand. farm. Sci., General Director of ANO "National Scientific pharmacovigilance center ", Moscow, anatoly.krasheninnikov@drugsafety.ru A. V. Matveev, Ph.D. honey. Sciences, Associate Professor of the Department of Internal Medicine No. 1 with a course of clinical Pharmacology Medical Academy. S. I. Georgievsky Federal State Autonomous Educational Institution of Higher Education "Crimean Federal University named [...]
R.S. Safiullin, A.E. Krasheninnikov In various national systems of the global global pharmacovigilance architecture, pharmaceutical workers have traditionally been one of the leading links in the collection and upstream channel of information on adverse events associated with drug use. The organization of pharmacovigilance determines the procedure for collecting spontaneous reactions about adverse drug events, as [...]
A.E. Krasheninnikov, Cand. farm. Sci., General Director of ANO "National Scientific pharmacovigilance center ", Moscow, anatoly.krasheninnikov@drugsafety.ru The spontaneous reporting method is the basis for the existence of the entire pharmacovigilance system both in the world and in a single country. The procedure for organizing pharmacovigilance involves receiving and registering messages. Improving the efficiency and quality [...]
Iron-containing drugs (iron-containing drugs) are a group of drugs containing elemental iron and necessary to replenish the reserve of iron ions in case of iron deficiency and the development of iron deficiency anemia (IDA). The study of the use of drug products in the framework of good pharmacovigilance practice showed an acceptable level of benefit [...]
It is known that pharmacovigilance (FN) performs a socially significant function of ensuring the safety of circulation of medicinal products (MP) both at the stages before registration of a medicinal product (MP) and at the stages after its registration. In the latter case, FN is called post-marketing. In post-marketing PH, pharmaceutical enterprises (FP) are delegated [...]
A significant amount of data from spontaneous messages about drug abuse, detected at the stages of clinical trials and post-registration circulation, as well as the legal requirements of the Rules of Good Pharmacovigilance Practice of the Eurasian Economic Union (EAEU), contribute to the introduction of information technologies in the system for collecting and analyzing messages [...]
